Brief Description
Apertor creates novel molecular glues for therapeutic applications in multiple disease areas. The company applies a world-class synthetic biology platform using non-model organisms, a deep knowledge of complex natural products relevant to human health, and a computational pipeline enabled by structure-guided design. The result is a first-in-class approach to solving important pharmacological problems and delivering new, high-value treatment options for patients. The company was co-founded by UC Berkeley Professor of Chemical & Biomolecular Engineering and of Bioengineering Jay Keasling.
Formerly known as Apertor Labs.
Inventors
Jay Keasling, Tyler W. H. Backman, Edmund Idris Graziani, Alan Martin Mathiowetz, Bo Pang
Company Founders
Edmund Graziani
Timeline
- 2020. Company founded